Somatropin (Genotropin) for subcutaneous injection long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
The objective of this systematic review is to compare the benefits and harms of Genotropin with other available somatropin products in children with growth hormone deficiency (GHD)
Format: | eBook |
---|---|
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2014, 2014
|
Series: | Common drug review clinical review report
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this systematic review is to compare the benefits and harms of Genotropin with other available somatropin products in children with growth hormone deficiency (GHD) |
---|---|
Item Description: | Title from title screen |
Physical Description: | 1 online resource illustrations |